The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infection

[1]  D. Yew,et al.  Gene Expression Changes in GABAA Receptors and Cognition Following Chronic Ketamine Administration in Mice , 2011, PloS one.

[2]  K. Jeang,et al.  MicroRNA silencing of tumor suppressor DLC‐1 promotes efficient hepatitis C virus replication in primary human hepatocytes , 2011, Hepatology.

[3]  A. Bell,et al.  Suppression of liver regeneration and hepatocyte proliferation in hepatocyte‐targeted glypican 3 transgenic mice , 2010, Hepatology.

[4]  M. Raiteri,et al.  The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings. , 2010, Cerebral cortex.

[5]  T. Berg,et al.  Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. , 2010, Trends in molecular medicine.

[6]  E. Majda-Stanisławska,et al.  Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. , 2009, Virus research.

[7]  A. Bordey,et al.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. , 2009, Physiology.

[8]  Tomasz P. Michalak,et al.  Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro , 2009, Hepatology.

[9]  G. Reynolds,et al.  University of Birmingham Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. , 2009 .

[10]  B. Birnir,et al.  GABA, a natural immunomodulator of T lymphocytes , 2008, Journal of Neuroimmunology.

[11]  R. Butterworth.  Pathophysiology of hepatic encephalopathy: The concept of synergism , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  R. Butterworth,et al.  Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  T. Pham,et al.  Occult persistence and lymphotropism of hepatitis C virus infection. , 2008, World journal of gastroenterology.

[14]  T. Pham,et al.  Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. , 2008, Gastroenterology.

[15]  A. Manira,et al.  Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation , 2008, Nature.

[16]  H. Blum,et al.  Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. , 2007, World journal of gastroenterology.

[17]  A. Zignego,et al.  Hepatitis C virus lymphotropism: lessons from a decade of studies. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[18]  H. Dienes,et al.  Decreased hepatocyte membrane potential differences and GABAa‐β3 expression in human hepatocellular carcinoma , 2007, Hepatology.

[19]  V. Carreño,et al.  Virus‐specific T‐cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection , 2006, Journal of medical virology.

[20]  A. Wolstenholme,et al.  Human peripheral blood mononuclear cells express GABAA receptor subunits. , 2006, Molecular immunology.

[21]  M. He,et al.  Neuronal activity regulates viral replication of herpes simplex virus type 1 in the nervous system , 2005, Journal of NeuroVirology.

[22]  C. Coffin,et al.  Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. , 2005, The Journal of general virology.

[23]  Hanwei Zhang,et al.  γ-Aminobutyric Acid Inhibits T Cell Autoimmunity and the Development of Inflammatory Responses in a Mouse Type 1 Diabetes Model1 , 2004, The Journal of Immunology.

[24]  Eric A. Barnard,et al.  Analysis of the Set of GABAA Receptor Genes in the Human Genome* , 2004, Journal of Biological Chemistry.

[25]  Manna Zhang,et al.  Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[26]  G. Minuk,et al.  Use of Fluoroquinolones in Patients with Chronic Hepatitis C Virus-Induced Liver Failure , 2002, Antimicrobial Agents and Chemotherapy.

[27]  J. Hoofnagle,et al.  Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.

[28]  Manna Zhang,et al.  Identification of γ-aminobutyric acid receptor subunit types in human and rat liver , 2000 .

[29]  P. Farmer,et al.  The pathogenesis of hepatic encephalopathy. , 1990, Annals of clinical and laboratory science.

[30]  J. Hoofnagle,et al.  SERUM LEVELS OF GAMMA-AMINOBUTYRIC-ACID-LIKE ACTIVITY IN ACUTE AND CHRONIC HEPATOCELLULAR DISEASE , 1983, The Lancet.

[31]  J. Brody,et al.  PROPHYLACTIC GAMMA GLOBULIN AND LIVE MEASLES VACCINE IN AN ISLAND OF MEASLES. , 1964, Lancet.

[32]  N. Assy,et al.  Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line. , 2000, Journal of hepatology.

[33]  M. Zhang,et al.  Identification of gamma-aminobutyric acid receptor subunit types in human and rat liver. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[34]  G. Minuk,et al.  The effect of gamma-aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats. , 1993, Gastroenterology.

[35]  G. Minuk,et al.  The effect of γ-Aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats , 1993 .